Hester Biosciences Ltd — Earnings Release 2022

May 20, 2022

==> picture [596 x 128] intentionally omitted <==

20 May 2022

To, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai 400 001

To, National Stock Exchange of India Limited Exchange Plaza, Bandra - Kurla Complex, Bandra (E), Mumbai 400 051

Scrip Code: 524669

Symbol: HESTERBIO

Dear Sir/ Madam:

Subject: Outcome of Board Meeting

This is with reference to our letter dated 12 May 2022 intimating the date of the Board Meeting for consideration of the Standalone and Consolidated Audited Financial Results for the quarter and year ended 31 March 2022 and to consider declaration of dividend, if any, on the equity shares of the Company, for the financial year 2021-22.

Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of Directors, in their Meeting held today, have approved the followings:

• 1. Audited Standalone and Consolidated Financial Results for the quarter and year ended 31 March 2022, as recommended by Audit Committee and the Audited Standalone and Consolidated Financial Statements for the year ended 31 March 2022.

Pursuant to Regulation 33 (3) (d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended time to time), we hereby state that the Statutory Auditors of the Company, Chadulal M. Shah & Co., Chartered Accountants (FRN: 101698W) have issued an Audit Report with unmodified opinion on the Audited Standalone and Consolidated Financial Results of the Company for the financial year ended on 31 March 2022.

• 1. Recommended dividend of 100% that is INR 10 per equity share of INR 10 each for the financial year 2021-22, subject to approval of members in the ensuing Annual General Meeting.

We attach herewith:

• 1. The approved standalone and consolidated audited financial results and auditors reports. 2) Press Release issued in this regard

We would be publishing the extract of results in the newspaper as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The Board Meeting commenced at 11:30 a.m. (IST) and concluded at 12:30 a.m. (IST)

==> picture [596 x 128] intentionally omitted <==

We shall inform you in due course the date on which the Company will hold its Annual General Meeting for the year ended 31 March 2022 and the date from which dividend, if approved by the shareholders, will be paid or warrants thereof dispatched to the shareholders.

You are requested to take the above information on your record.

Sincerely For Hester Biosciences Limited

==> picture [76 x 37] intentionally omitted <==

Vinod Mali Company Secretary & Compliance Officer

Enclosure: As above